Introduction and Objective: Aging is a complex biological process with pronounced metabolic dysfunction, which is exacerbated by obesity. During aging, adipose tissue is vulnerable and functions as a driver of age-related diseases. Adipose tissue progenitors are responsive to aged environment. However, the key regulator involved in adipose aging process remains obscure. Methods: Progenitor-specific SETD2 knockout mice, adipocyte-specific SETD2 knockout mice and littermates were fed with chow or HFHS diet for 16 weeks. The glucose tolerance test and insulin tolerance test were performed. H&E staining, Sirius red staining and immunohistochemical staining were used for adipose tissue analysis. Coimmunoprecipitations were used for identification of C/EBPα as a SETD2 binding protein. Results: We show that lysine methyltransferase SETD2 is an essential regulator of adipose tissue aging via maintaining differentiation capacity of progenitors and metabolic function of mature adipocytes. Compared with young mice, SETD2 was significantly decreased in white adipose tissue of 20 months aged mice. Progenitor-specific SETD2 deficiency remarkably reduced body weight, caused defective development of adipocytes and exacerbated systemic metabolic disorders. Adipocyte-specific SETD2 deficiency aggravated age-related adipose hypertrophy, inflammation, fibrosis and expression levels of aging markers, p16 and p21, in obese mice fed with HFHS. Mechanistically, SETD2 is sufficient to interact with C/EBPα, thereby facilitating genes related to differentiation and development. Importantly, SETD2 is decreased in adipose tissues of obese humans and positively associated with improved metabolic function. Conclusion: Collectively, this study uncovered a novel mechanism in adipose tissue aging process, targeting SETD2 may provide therapeutic strategies for the treatment of age-related metabolic diseases, such as type 2 diabetes and obesity. Disclosure D. Ding: None. Z. Zheng: None. S. Wei: None. W. Li: None. J. Shen: None. J. Lin: None. M. Huang: None. L. Li: None. Z. Liu: None. K. Qian: None. T. Zhang: None. J. Zhao: None. Y. Jiang: None. W. Su: None. Y. Li: None. A. Cui: None. Funding National Key R&D Program of China (2019YFA0802502, 2023YFA1801100), National Natural Science Foundation of China (81925008, 32130047), Project supported by Shanghai Municipal Science and Technology Major Project, Open Project Program of Metabolic Vascular Diseases Key Laboratory of Sichuan Province (2022MVDKL-K2)